Targets for Combating the Evolution of Acquired Antibiotic Resistance
Author(s) -
Matthew J. Culyba,
Charlie Y. Mo,
Rahul M. Kohli
Publication year - 2015
Publication title -
biochemistry
Language(s) - English
Resource type - Journals
eISSN - 1520-4995
pISSN - 0006-2960
DOI - 10.1021/acs.biochem.5b00109
Subject(s) - antibiotic resistance , antibiotics , biology , drug resistance , somatic hypermutation , computational biology , horizontal gene transfer , resistance (ecology) , gene , genetics , genome , ecology , b cell , antibody
Bacteria possess a remarkable ability to rapidly adapt and evolve in response to antibiotics. Acquired antibiotic resistance can arise by multiple mechanisms but commonly involves altering the target site of the drug, enzymatically inactivating the drug, or preventing the drug from accessing its target. These mechanisms involve new genetic changes in the pathogen leading to heritable resistance. This recognition underscores the importance of understanding how such genetic changes can arise. Here, we review recent advances in our understanding of the processes that contribute to the evolution of antibiotic resistance, with a particular focus on hypermutation mediated by the SOS pathway and horizontal gene transfer. We explore the molecular mechanisms involved in acquired resistance and discuss their viability as potential targets. We propose that additional studies into these adaptive mechanisms not only can provide insights into evolution but also can offer a strategy for potentiating our current antibiotic arsenal.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom